Summit Therapeutics Statistics
Total Valuation
SMMT has a market cap or net worth of $6.17 billion. The enterprise value is $6.11 billion.
| Market Cap | 6.17B |
| Enterprise Value | 6.11B |
Important Dates
The next estimated earnings date is Wednesday, August 7, 2024, before market open.
| Earnings Date | Aug 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SMMT has 701.97 million shares outstanding.
| Shares Outstanding | 701.97M |
| Owned by Insiders (%) | 88.14% |
| Owned by Institutions (%) | 7.28% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 23.12.
| PE Ratio | 23.12 |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 108.02 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.97, with a Debt / Equity ratio of 2.48.
| Current Ratio | 6.97 |
| Quick Ratio | n/a |
| Debt / Equity | 2.48 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -136.10% and return on invested capital (ROIC) is -74.73%.
| Return on Equity (ROE) | -136.10% |
| Return on Assets (ROA) | -55.50% |
| Return on Capital (ROIC) | -74.73% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.11M |
| Employee Count | 105 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +316.35% in the last 52 weeks. The beta is -0.98, so SMMT's price volatility has been lower than the market average.
| Beta (5Y) | -0.98 |
| 52-Week Price Change | +316.35% |
| 50-Day Moving Average | 7.03 |
| 200-Day Moving Average | 4.14 |
| Relative Strength Index (RSI) | 55.98 |
| Average Volume (20 Days) | 2,646,052 |
Short Selling Information
| Short Interest | 20.31M |
| Short Previous Month | 23.43M |
| Short % of Shares Out | 24.38% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.68 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -148.36M |
| Pretax Income | -149.83M |
| Net Income | -116.03M |
| EBITDA | -147.63M |
| EBIT | -149.83M |
| Earnings Per Share (EPS) | -$0.00 |
Balance Sheet
The company has $202.74 million in cash and $141.43 million in debt, giving a net cash position of $61.31 million or $0.09 per share.
| Cash & Cash Equivalents | 202.74M |
| Total Debt | 141.43M |
| Net Cash | 61.31M |
| Net Cash Per Share | $0.09 |
| Equity (Book Value) | 57.09M |
| Book Value Per Share | 0.08 |
| Working Capital | 180.56M |
Cash Flow
In the last 12 months, operating cash flow was -$121.08 million and capital expenditures $189,827, giving a free cash flow of -$120.89 million.
| Operating Cash Flow | -121.08M |
| Capital Expenditures | 189,827 |
| Free Cash Flow | -120.89M |
| FCF Per Share | -$0.17 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SMMT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -85.58% |
| Shareholder Yield | -85.58% |
| Earnings Yield | -1.88% |
| FCF Yield | -1.96% |
Analyst Forecast
The average price target for SMMT is $13.50, which is 53.67% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.50 |
| Price Target Difference | 53.67% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 82.72% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | Sep 21, 2020 |
| Split Type | n/a |
| Split Ratio | 1:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |